Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| MUSTANG BIO, INC.MBIO · Entity 8350 | Director | December 30, 2025 | December 30, 2025 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
MUSTANG BIO, INC.
Report date December 30, 2025 · Filed December 30, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| COMMON STOCK, PAR VALUE $0.0001SEC Table I · non-derivative | Direct | 375 |
Reported balance
After 2025-12-30 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2025-12-30 · Sale · Disposed 4 · Balance 375 F1: Effective January 15, 2025, the Issuer effected a one-for-fifty reverse stock split of its common stock (the "Reverse Stock Split"). The amount of common stock reflected on this Form 4 has been adjusted to reflect the Reverse Stock Split. |
Filing footnotes · ownership attribution and instrument terms
F1: Effective January 15, 2025, the Issuer effected a one-for-fifty reverse stock split of its common stock (the "Reverse Stock Split"). The amount of common stock reflected on this Form 4 has been adjusted to reflect the Reverse Stock Split.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| December 30, 2025 Filed Dec 30, 2025 16:16 UTC | MUSTANG BIO, INC. MBIO · Entity 8350 | SaleCOMMON STOCK, PAR VALUE $0.0001 | 4 | $0.95 | $3.82 |
DisclosureSEC source: 0001104659-25-125232 · tm2534509-2_4seq1.xml · nonDerivative · entry 1 Chill Adam J. · CIK 0001626451 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 375 F1 · balance_after: Effective January 15, 2025, the Issuer effected a one-for-fifty reverse stock split of its common stock (the "Reverse Stock Split"). The amount of common stock reflected on this Form 4 has been adjusted to reflect the Reverse Stock Split. Read SEC document |
| July 05, 2023 Filed Jul 7, 2023 16:07 UTC | MUSTANG BIO, INC. MBIO · Entity 8350 | GrantCOMMON STOCK, PAR VALUE $0.0001 | 7,246 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-23-079117 · tm2320790-5_4seq1.xml · nonDerivative · entry 1 Chill Adam J. · CIK 0001626451 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,170 F1 · shares: The Reporting Person was granted 7,246 restricted shares pursuant to the Issuer's 2016 Incentive Plan on July 5, 2023. The shares will vest on July 5, 2026, subject to the Reporting Person's continued service on the Issuer's board on such date. F2 · shares: Effective April 3, 2023, the Issuer effected a fifteen-for-one reverse stock split of its common stock (the "Reverse Stock Split"). The amount of common stock reflected on this Form 4 has been adjusted to reflect the Reverse Stock Split. F2 · balance_after: Effective April 3, 2023, the Issuer effected a fifteen-for-one reverse stock split of its common stock (the "Reverse Stock Split"). The amount of common stock reflected on this Form 4 has been adjusted to reflect the Reverse Stock Split. F3 · balance_after: Includes restricted share units, which vest over various time periods. Read SEC document |
| July 29, 2022 Filed Apr 3, 2023 16:48 UTC | MUSTANG BIO, INC. MBIO · Entity 8350 | GrantCOMMON STOCK, PAR VALUE $0.0001 | 71,664 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-23-040924 · tm2311237-2_4seq1.xml · nonDerivative · entry 1 Chill Adam J. · CIK 0001626451 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 178,861 F1 · shares: The Reporting Person was granted 71,664 restricted shares pursuant to the Issuer's 2016 Incentive Plan on July 29, 2022. The shares will vest on June 17, 2025, subject to the Reporting Person's continued service on the Issuer's board on such date. F2 · balance_after: Includes restricted share units, which vest over various time periods. Read SEC document |
| June 28, 2021 Filed Jul 8, 2021 16:31 UTC | MUSTANG BIO, INC. MBIO · Entity 8350 | GrantCOMMON STOCK | 13,774 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-21-090239 · tm2121675-1_4seq1.xml · nonDerivative · entry 1 Chill Adam J. · CIK 0001626451 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 107,197 F1 · shares: The Reporting Person was granted 13,774 restricted shares pursuant to the Issuer's 2016 Incentive Plan on June 28, 2021. The shares will vest on June 17, 2024, subject to the Reporting Person's continued service on the Issuer's board on such date. F2 · balance_after: Includes restricted share units, which vest over various time periods. Read SEC document |
| July 14, 2020 Filed Aug 19, 2020 16:32 UTC | MUSTANG BIO, INC. MBIO · Entity 8350 | GrantCommon Stock | 16,611 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-20-096923 · tm2028955d1_4.xml · nonDerivative · entry 1 Chill Adam J. · CIK 0001626451 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 93,423 F1 · balance_after: 93,423 shares are restricted Common Stock which vest over various time periods. Read SEC document |
| August 28, 2019 Filed Jan 17, 2020 17:44 UTC | MUSTANG BIO, INC. MBIO · Entity 8350 | GrantCommon Stock | 13,812 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-20-005210 · tm203350d3_form4.xml · nonDerivative · entry 1 Chill Adam J. · CIK 0001626451 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 76,812 F1 · balance_after: 73,812 shares are restricted Common Stock which vest over various time periods. Read SEC document |
| November 12, 2018 Filed Nov 13, 2018 06:37 UTC | MUSTANG BIO, INC. MBIO · Entity 8350 | GrantCOMMON STOCK | 1,000 | $4.85 | $4,850.00 |
DisclosureSEC source: 0001144204-18-058924 · tv507044_form4.xml · nonDerivative · entry 3 Chill Adam J. · CIK 0001626451 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 63,000 F1 · balance_after: 60,000 shares are restricted Common Stock which vest over various time periods. Read SEC document |
| November 08, 2018 Filed Nov 13, 2018 06:37 UTC | MUSTANG BIO, INC. MBIO · Entity 8350 | GrantCOMMON STOCK | 2,000 | $5.34 | $10,680.00 |
DisclosureSEC source: 0001144204-18-058924 · tv507044_form4.xml · nonDerivative · entry 2 Chill Adam J. · CIK 0001626451 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 62,000 F1 · balance_after: 60,000 shares are restricted Common Stock which vest over various time periods. F2 · balance_after: Reflects the weighted average purchase price of multiple same-way open market purchase transactions effected by the Reporting Person on the same day at different prices through a purchase order executed by a broker-dealer. The reporting person reported on a single line all such transactions that occurred within a one dollar price range. The range of prices for the purchase transactions on November 8, 2018, was $4.90 to $6.06. The reporting person hereby undertakes to provide upon request by the Securities Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares purchased at each separate price. Read SEC document |
| June 14, 2018 Filed Nov 13, 2018 06:37 UTC | MUSTANG BIO, INC. MBIO · Entity 8350 | GrantCOMMON STOCK | 10,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001144204-18-058924 · tv507044_form4.xml · nonDerivative · entry 1 Chill Adam J. · CIK 0001626451 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,000 F1 · balance_after: 60,000 shares are restricted Common Stock which vest over various time periods. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.